Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome - A randomized placebo-controlled trial

被引:87
作者
Chan, CCW
Koo, MWL
Ng, EHY
Tang, OS
Yeung, WSB
Ho, PC
机构
[1] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Pharmacol, Hong Kong, Hong Kong, Peoples R China
关键词
green tea; polycystic ovary syndrome; body weight; hormonal profile; biochemical profile;
D O I
10.1016/j.jsgi.2005.10.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVES: To study the effects ofgrecn tea on body weight, and biochemical and hormonal profiles in obese Chinese women with polycystic ovary syndrome (PCOS). METHODS: Thirty-four obese Chinese women with PCOS were randomized into either treatment with green tea capsules or placebo for 3 months. The anthropometric measurements, and biochemical and hormonal profiles before and after treatment in each group were compared. RESULTS: The body weight of the green tea group decreased by a nonsignificant 2.4% after treatment; whereas the body weight, body mass index (BMI), and body fat content of the control group were significantly higher after 3 months. There were no differences in any of the hormone levels measured in either group. The biochemical profiles of the two groups were also similar except that there was a small but significant rise in the triglyceride level in the green tea group. Fewer patients in the green tea group remained amenorrhoeic, but this was not significantly different from the control group. CONCLUSIONS: Green tea supplementation did not significantly reduce body weight in obese women with PCOS, nor did it alter the glucose or lipid metabolism.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 27 条
[1]   Influence of age on the thermic response to caffeine in women [J].
Arciero, PJ ;
Bougopoulos, CL ;
Nindl, BC ;
Benowitz, NL .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (01) :101-107
[2]   CAFFEINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ITS THERMOGENIC, METABOLIC, AND CARDIOVASCULAR EFFECTS IN HEALTHY-VOLUNTEERS [J].
ASTRUP, A ;
TOUBRO, S ;
CANNON, S ;
HEIN, P ;
BREUM, L ;
MADSEN, J .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 51 (05) :759-767
[3]   CATECHOL O-METHYLTRANSFERASE .5. STRUCTURE-ACTIVITY-RELATIONSHIPS FOR INHIBITION BY FLAVONOIDS [J].
BORCHARDT, RT ;
HUBER, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (01) :120-122
[4]   EFFECTS OF CAFFEINE ON ENERGY-METABOLISM, HEART-RATE, AND METHYLXANTHINE METABOLISM IN LEAN AND OBESE WOMEN [J].
BRACCO, D ;
FERRARRA, JM ;
ARNAUD, MJ ;
JEQUIER, E ;
SCHUTZ, Y .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 269 (04) :E671-E678
[5]   Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity [J].
Chantre, P ;
Lairon, D .
PHYTOMEDICINE, 2002, 9 (01) :3-8
[6]  
Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
[7]   HYPERANDROGENIC ANOVULATION (PCOS) - A UNIQUE DISORDER OF INSULIN ACTION ASSOCIATED WITH AN INCREASED RISK OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
DUNAIF, A .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 :S33-S39
[8]   Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Barnes, RB ;
Rosenfield, RL ;
Cavaghan, MK ;
Imperial, J .
DIABETES CARE, 1999, 22 (01) :141-146
[9]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].
Fauser, BCJM ;
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
HUMAN REPRODUCTION, 2004, 19 (01) :41-47
[10]   MEDICAL PROGRESS - POLYCYSTIC-OVARY-SYNDROME [J].
FRANKS, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (13) :853-861